MedTrace Logo

Impact of Daylight on Patients With Acute Myocardial Infarction

NCT02490397 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-06-07

No results posted yet for this study

Summary

The study tests if intense light could be a potential therapy in humans after myocardial infarction by inducing Per2.

Conditions

Interventions

OTHER

Day Light

Patients are exposed to day light for 2 weeks after a heart attack. At the end of 2 weeks they will have blood drawn.

OTHER

Room Light

Patients will be exposed to only room or natural light for 2 weeks after heart attack. At the end of 2 weeks they will have blood drawn.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Tobias Eckel, MD, PhD · University of Colorado, Denver

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2020-12-28
Completion
2020-12-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490397 on ClinicalTrials.gov